DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study
Abstract Background Metabolic side effects of psychotropic medications are a major drawback to patients’ successful treatment. Using an epigenome-wide approach, we aimed to investigate DNA methylation changes occurring secondary to psychotropic treatment and evaluate associations between 1-month met...
Main Authors: | Céline Dubath, Eleonora Porcu, Aurélie Delacrétaz, Claire Grosu, Nermine Laaboub, Marianna Piras, Armin von Gunten, Philippe Conus, Kerstin Jessica Plessen, Zoltán Kutalik, Chin Bin Eap |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Clinical Epigenetics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13148-024-01648-4 |
Similar Items
-
DNA methylation may mediate psychotropic drug-induced metabolic side effects: results from a 1-month observational study
by: C. Dubath, et al.
Published: (2022-06-01) -
Effects of psychotropic switches on weight change: a prospective cohort study
by: M. Piras, et al.
Published: (2022-06-01) -
Psychotropic-induced weight gain and telomere length: results from a one-year longitudinal study and a large population-based cohort
by: Marianna Piras, et al.
Published: (2024-11-01) -
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
by: Nermine Laaboub, et al.
Published: (2022-05-01) -
Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort
by: Nermine Laaboub, et al.
Published: (2022-07-01)